Kaiser Permanente

Medications

Paxlovid associated with lower risk of hospital admission

A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless of prior immunity ...

Diseases, Conditions, Syndromes

Increased health care use among patients after COVID-19

A study led by Kaiser Permanente in Southern California of patients from eight health care organizations across the United States showed that COVID-19 was associated with a 4% increase in use of health care services over ...

Diseases, Conditions, Syndromes

Shorter wait between COVID-19 and elective surgery possible

Kaiser Permanente researchers have good news for patients, surgeons, anesthesiologists, and hospital administrators who have had to put off elective surgery because of a positive COVID-19 test. Among fully vaccinated patients, ...

Health

Lifestyle coaching lowers blood pressure in Black adults

Culturally tailored lifestyle coaching can help Black adults with hypertension improve their blood pressure control, new Kaiser Permanente research shows. Improving blood pressure control is key to reducing risk for stroke, ...

page 3 from 32